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VP5, the major capsid protein of herpes simplex virus type 1 (HSV-1), interacts with the C-terminal residues of the scaffold
molecules encoded by the overlapping UL26 and UL26.5 open reading frames. Scaffold molecules are cleaved by a UL26
encoded protease (VP24) as part of the normal capsid assembly process. In this study, residues of VP5 have been identified
that alter its interaction with the C-terminal residues of the scaffold proteins. A previously isolated virus (KUL26-610/611) was
used that encoded a lethal mutation in the UL26 and UL26.5 open reading frames and required a transformed cell line that
expresses these proteins for virus growth. The scaffold maturation cleavage site between amino acids 610 and 611 was
blocked by changing Ala-Ser to Glu-Phe, which generated a new EcoRI restriction site. Revertant viruses, that formed small
plaques on nontransformed cells, were detected at a frequency of 1:3800. Nine revertants were isolated, and all of them
retained the EcoRI site and therefore were due to mutations at a second site. The second site mutations were extragenic.
Using marker-transfer techniques, the mutation in one of the revertants was mapped to the 59 region of the gene encoding
VP5. DNA sequence analysis was performed for the N-terminal 571 codons encoding VP5 for all of the revertant viruses. Six
of the nine revertants showed a single base pair change that caused an amino acid substitution between residues 30 and
78 of VP5. Three of these were identical and changed Ala to Val at residue 78. The data provide a partial map of residues
of VP5 that alter its interaction with scaffold proteins blocked at their normal cleavage site. The yeast two-hybrid system was
used as a measure of the interaction between mutant VP5 and scaffold molecules and varied from 11% to nearly 100%,
relative to wild-type VP5. One revertant gave no detectable interaction by this assay. The amount of UL26 encoded protease
(VP24) in B capsids for KUL26-610/611 and for revertants was 7% and 25%, respectively, relative to the amount in capsids for
wild-type virus. The lack of retention of the viral protease in the mutant virus and a fourfold increase for the revertants
suggest an additional essential function for VP24 in capsid maturation, and a role in DNA packaging is indicated. © 1999
Academic Press
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OINTRODUCTION
Three capsid types can be isolated from herpes sim-
lex virus type 1 (HSV-1)-infected cells, designated A, B,
nd C in terms of increasing distance sedimented
hrough sucrose gradients (Gibson and Roizman, 1972).
capsids contain internal scaffold proteins, the viral
rotease, and the capsid shell proteins. For C capsids,
enomic DNA replaces the scaffold proteins. A capsids
re thought to result after abortive attempts at DNA
ackaging. The HSV-1 B capsid is composed of seven
apsid proteins. Their designation and the open reading
rame (ORF) encoding the proteins are VP5 (UL19),
P19C (UL38), 21 (UL26), 22a (UL26.5), VP23 (UL18),
P24 (UL26), and VP26 (UL35) (Cohen et al., 1980; Gib-
on and Roizman, 1972; Heilman et al., 1979; McGeoch et
l., 1988; for a review, see Steven and Spear, 1996). VP is
sed to designate proteins that are incorporated into the
1 To whom reprint requests should be addressed. Fax: (410) 955-
a023.
357irus particle. VP5, the major capsid protein, forms the
exons and pentons present in capsid shells (Booy et al.,
991; Newcomb et al., 1991, 1993; Zhou et al., 1995).
djacent molecules of VP5 in pentons and hexons are
eld together, mainly, by a complex of VP19C and VP23
Newcomb et al., 1993; Trus et al., 1996; Zhou et al., 1994).
P26, located at the outer surface of VP5 hexons but not
entons, is not essential for viral replication or capsid
ormation (Booy et al., 1994; Desai et al., 1998; Newcomb
t al., 1996; Tatman et al., 1994; Thomsen et al., 1994;
rus et al., 1995; Zhou et al., 1995). Capsid assembly for
erpesviruses begins in the cytoplasm. Separate com-
lexes of VP5 and 22a and of VP19C and VP23 are
hought to form in the cytoplasm and initiate B capsid
ormation after their transport to the nucleus (Nicholson
t al., 1994; Rixon et al., 1996).
Three B capsid proteins are encoded by the UL26 and
L26.5 ORFs from two 39 coterminal transcripts (Holland
t al., 1984; Liu and Roizman, 1991a) (Fig. 1). The UL26
RF (635 amino acid residues) encodes a protease (Liu
nd Roizman, 1991b; Preston et al., 1992) and cleavage
0042-6822/99 $30.00
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358 DESAI AND PERSONccurs at two sites, between amino acid residues 610
nd 611 (scaffold maturation) and between residues 247
nd 248 (protease release) (DiIanni et al., 1993). The
roteolytic activity specified by UL26 has been localized
o the N-terminal 247 residues (Liu and Roizman, 1993;
einheimer et al., 1993). The products of the release site
leavage generate proteins VP24 (residues 1–247) and
1 (248–635) (Weinheimer et al., 1993). Throughout the
ext, UL26 ORF numbers are used to designate residues
n VP24, 21, or 22a. The more abundant 22a is encoded
y the UL26.5 transcript, and translation starts at codon
07 in phase with the UL26 ORF (Liu and Roizman,
991a,b). Therefore, 21 and 22a are identical in amino
cid sequence between residues 307–635, and both
roteins can function as scaffolds during the formation of
capsids (Tatman et al., 1994; Thomsen et al., 1994). In
ontrast to the scaffold molecules (21 plus 22a), the
rotease (VP24) is present at much lower copy numbers
nd is a virion protein.
The 25 amino acids C-terminal to the scaffold matura-
ion site specified by UL26 and UL26.5 are necessary
nd sufficient for interaction with VP5 during capsid
ormation (Desai and Person, 1996; Hong et al., 1996;
ennard et al., 1995; Thomsen et al., 1995). Capsid shells,
ut not sealed capsids, are formed in the absence of the
-terminal 25 amino acids (Kennard et al., 1995; Matu-
ick-Kumar et al., 1995; Thomsen et al., 1994). For the
eaction with VP5, the minimal UL26 and UL26.5 interac-
ion sequence was mapped to residues 622–633 using a
ST-pulldown assay (Hong et al., 1996). Covalent bond
leavage by protease between amino acids 610 and 611
rees the scaffold molecules from VP5 and allows capsid
aturation, including DNA packaging, to proceed.
Recently we reported the isolation and some of the
roperties of a mutant virus altered at the protease
leavage site at residues 610 and 611 of the UL26 and
L26.5 ORFs (Person and Desai, 1998). Codons encod-
ng Ala-Ser were changed to those encoding Glu-Phe
GCCAGC to GAATTC, which encodes a new EcoRI re-
triction enzyme site). The mutant designated KUL26-
FIG. 1. Gene products of the UL26 and UL26.5 ORFs. UL26 encodes
635-residue protein with autocatalytic protease activity that cleaves
etween residues 247 and 248 (protease release site) to generate
P24 and 21. 22a is encoded by UL26.5, and translation initiation
ccurs at residue 307. Both 21 and 22a are cleaved by the protease
etween residues 610 and 611 (scaffold maturation site).10/611 formed plaques only on transformed cells that axpress UL26 and UL26.5 proteins, so the mutation was
ethal. Infection of nonpermissive (nontransformed) cells
evealed that capsid assembly stopped at the B capsid
tage. Blockage of the cleavage site between residues
10 and 611 was confirmed by the decreased mobilities
f the scaffold proteins (22a and 21). The presence of
rotein 21 in the mutant B capsids demonstrated that
leavage had occurred between residues 247 and 248.
lthough the synthesis and cleavage (at the protease
elease site) of the UL26 gene products seemed normal
n mutant infected Vero cells, VP24 was absent or
resent in a very low copy number in the B capsids.
ecause protease cleavage must occur inside newly
ormed B capsids, VP24 was largely lost from the cap-
ids. Therefore, cleavage between residues 610 and 611
eems to be required for the retention of VP24 in cap-
ids.
There was a second unusual property of KUL26-610/
11. Normally, viruses form plaques after 2–3 days of
ncubation, and that was the case for the mutant virus
hen plated onto UL26-transformed cells. However,
hen plated onto nontransformed cells, some small
laques appeared that were more evident after a fourth
ay of incubation. The plaques represented reversion
vents whose properties are presented here. Reversion
f mutations can occur, as the name implies, via a re-
ersal of the original mutation to the wild type or by the
ormation of a second mutation that suppresses, or over-
omes, the effect of the original mutation. The spontane-
us mutations reported here were suppressor mutations
hat have been localized to the 59 region of the gene
ncoding VP5. There have been two reports of intragenic
uppressor mutations in regulatory genes of HSV-1: one
n ICP4 (Shepard and DeLuca, 1991) and the other in
CP27 (Soliman et al., 1997). Until now, there have been
o reports of intergenic suppressor mutations for HSV-1.
RESULTS
In an earlier study, Vero cells were transformed with
NA fragments encoding the essential capsid proteins
f HSV-1, and a cell line, designated C32, was isolated
hat expressed these proteins upon infection with vi-
uses encoding mutations in the capsid genes (Person
nd Desai, 1998). Therefore, C32 cells are referred to as
ermissive cells, and the nontransformed Vero cells are
eferred to as nonpermissive. When KUL26-610/611 virus
as plated onto monolayers of Vero cells, small plaques
ppeared at a frequency of less than 1% relative to larger
laques formed on C32 cells. Several of the plaques
ormed after infection of Vero cells were tested, and all
rew on Vero cells after repeated passage. Therefore,
hese plaques were not due to a leaky phenotype be-
ause they no longer required the permissive cell line for
rowth but rather are due to spontaneous mutations that
llow them to overcome the lethal effect of the blocked
c
g
R
i
v
o
a
K
e
t
w
T
s
t
l
P
p
p
E
s
e
E
o
K
6
E
1
r
r
t
c
t
T
o
g
p
t
f
f
w
t
i
P
t
a
s
s
K
P
i
w
C
p
s
m
a
t
b
c
t
t
t
s
m
(
K
l
I
s
t
c
a
p
d
p
i
e
i
359MAJOR CAPSID PROTEIN (VP5) AND HSV-1leavage site. Hence, the small plaques resulted from
enetic changes and were revertant viruses.
evertants are caused by second site mutations
To determine the spontaneous reversion frequency, 20
ndividual plaques were isolated on 96-well trays, har-
ested, and titered on Vero and C32 cells. The virus titer
n Vero cells measures the number of revertant viruses,
nd the titer on C32 cells measures the number of
UL26-610/611 and revertant viruses. For the 20 plaques
xamined, the average PFU on Vero cells was 17.8, and
hat on C32 cells was 8.4 3 104. The range of the PFU
as 0–73 for Vero cells and 0.9–21 3 104 for C32 cells.
he ratio of the average titers is a measure of the rever-
ion frequency and was 2.6 3 1024, which corresponds
o 1 revertant/3800 total PFU.
Revertant viruses from nine single plaques were iso-
ated from Vero cell monolayers and designated PR1–
R9. PR1 and PR2 were isolated from the same virus
reparation. PR3–PR9 were isolated from individual
laques used in the reversion frequency experiment.
ach of the viruses was plaque-purified twice, and virus
tocks were prepared on Vero cells. Viral DNAs were
xamined by Southern blotting for the presence of the
coRI restriction site generated during the construction
f KUL26-610/611. Data are shown in Fig. 2 for KOS,
UL26-610/611, PR1, PR2, PR3, PR5, and PR7. For KUL26-
10/611, the introduction of an EcoRI site into the 16.1-kb
coRI-F fragment resulted in its cleavage into 4.6- and
1.5-kb fragments by EcoRI. PR1, PR2, PR3, PR5, and PR7
etained the restriction enzyme site, as did the remaining
evertants (data not shown). Therefore, all of the rever-
ants were due to mutations at a second site that over-
ame the block at the scaffold maturation site and were
herefore suppressor mutations.
he second site mutations are extragenic
The origin of suppressors mutations may be intragenic
r extragenic. Intragenic suppressor mutations in the
enes encoding scaffold proteins could create additional
FIG. 2. Genome analysis of revertant viruses. Infected cell DNA was
igested with EcoRI, and the fragments were resolved by gel electro-
horesis and subjected to Southern blot analysis. Filters were hybrid-
zed to 32P-labeled DNA corresponding to the NotI fragment (6.5 kb) that
ncodes UL26 and UL26.5. The sizes of the hybridized fragments are
ndicated in kb.rotease cleavage sites. To determine whether this was uhe case, capsids were prepared and their protein pro-
iles were analyzed by SDS–PAGE. Vero cells were in-
ected with revertant viruses and radioactively labeled
ith 35S-methionine. After sedimentation of nuclear ex-
racts, fractions containing B and C capsids were exam-
ned by SDS–PAGE. Results are shown in Fig. 3 for KOS,
R2, PR3, and PR7. Profiles for B capsids are shown on
he right. Radioactivity at the mobility of 22a for KOS was
bsent in the revertant viruses and was replaced with a
ingle band of decreased mobility. The profiles were
imilar to those for B capsids obtained from the growth of
UL26-610/611 on Vero cells (Person and Desai, 1998).
rofiles for C capsids lack uncleaved 21 and 22a, which
mplies that scaffold molecules can leave the capsids
ithout protease cleavage. This also implies that the 25
-terminal residues of scaffold proteins, the C-terminal
roduct of protease cleavage, do not function in a later
tep in capsid maturation. The amount of VP24 was
arkedly reduced for B capsids from the revertants rel-
tive to KOS. Results shown in Figs. 2 and 3 demonstrate
hat cleavage between residues 610 and 611 remained
locked in the revertant viruses, and no obvious new
leavage sites were generated. All nine revertants had
he same phenotype (data not shown). In addition, marker-
ransfer experiments indicated that the suppressor mu-
ations were not in the UL26 and UL26.5 ORFs (see next
ection). Therefore, we conclude that the suppressor
utations are extragenic.
FIG. 3. Capsids formed by revertant viruses. Vero cell monolayers
approximately 107 cells in 100-mm Petri dishes) were infected with
OS and the indicated revertant viruses at an m.o.i. of 5 PFU/cell and
abeled with 35S-methionine (200 mCi) from 8 to 24 h postinfection.
nfected cells were harvested, and nuclear lysates were prepared,
onicated, sedimented through 20–50% sucrose gradients, and frac-
ionated. The radioactivity was measured for each fraction. Fractions
orresponding to B and C capsids were analyzed by SDS–PAGE (17%
crylamide) (Person and Desai, 1998). The mobilities of B capsid
roteins for KOS are indicated on the right of the figure. The position of
ncleaved 22a is marked ( z ).
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360 DESAI AND PERSONhe suppressor mutation in PR7 maps
o the N-terminus of VP5
Because VP5 and the scaffold proteins are known to
nteract, it is likely that the second site mutations are in
he UL19 ORF encoding VP5. To determine whether this
as the case, a marker-transfer assay was used (Person
nd Desai, 1998). KUL26-610/611 genomic DNA was co-
ransfected into C32 cells along with plasmid DNA con-
aining cloned restriction fragments from one of the re-
ertants. Homologous recombination between a restric-
ion fragment (containing the second mutation) and the
UL26-610/611 genome (encoding the original mutation)
ill give rise to progeny viruses that contain both muta-
ions and yield small plaques on Vero cells.
Using a pool of 13 EcoRI genomic fragments repre-
enting the entire PR7 genome, approximately 20% of the
laques that formed on C32 cells also grew on Vero
ells. When a plasmid containing the EcoRI G fragment
encoding genes UL16–UL21) was used, 7.4% of the
laques on C32 cells gave small plaques on Vero cells
s well. A subclone of EcoRI G fragment (the 5.7-kb BglII
fragment) that encoded only UL19 (VP5) was also
ositive (26.3%), whereas a NotI subclone of EcoRI F that
ncodes only the UL26 and UL26.5 genes gave back-
round levels of marker transfer (generally 0.1–0.50%). In
single experiment, cleavage of the BglII N clone with
he restriction enzyme HindIII reduced the marker trans-
er to background levels, and in repeated experiments, it
lways gave a significant reduction in marker transfer
elative to the value for the clone encoding uncleaved
glII N. The HindIII site cleaves at nucleotides encoding
mino acid residue 226 of VP5. We conclude that the
utation in PR7 that overcomes the effect of the blocked
leavage site in the scaffold proteins must be near the
indIII site. Cleavage of the BglII N clone with other
estriction enzymes gave results consistent with that of
he above result. A detailed analysis by marker transfer
as not carried out because the spontaneous reversion
requency of 1:3800 (0.03%) approached the marker
ransfer background and because we intended to deter-
ine the DNA sequence of PR7 and the other revertants
n the HindIII region of UL19 (VP5).
econd site mutations in the gene encoding VP5
Sequence analysis of the 59 region of the gene encod-
ng VP5 (UL19) was carried out to determine the nature of
he spontaneous mutations for the revertant viruses. The
NA sequence of the revertants was compared with
hose of KOS, KUL26-610/611, and strain 17 (McGeoch et
l., 1988). The sequence was determined for 1713 bp
pecifying the first 571 codons and some 59 flanking
ucleotides of UL19. The altered nucleotides and codons
nd the resulting amino acid substitutions for each re-
ertant are shown in Table 1. The altered bases are
nderlined. Eight of the nine revertants resulted from single amino acid changes. PR3 had two amino acid
hanges (43 and 365). Seven of the revertants had amino
cid changes between residues 30 and 78. Three had
he identical amino acid substitution at residue 78 (PR2,
R6, and PR8). Changes in PR4 and PR1 were at resi-
ues 166 and 319, respectively.
To test the unlikely possibility that PR3 was a mixture
f two revertants, the pKKI plasmid encoding PR3 was
sed to transform bacteria a second time, a single colony
as isolated, and the DNA sequence was determined.
he same nucleotide changes were found, so PR3 did
rise from two mutations. The probability of two rever-
ion events in a single plaque is the square of the
robability for a single event (2.6 3 1024) multiplied by
he total number of PFU/plaque (8.4 3 104), or 2.2 3 1023.
his corresponds to 1 in 169 isolates.
KOS, KUL26-610/611, and all of the revertants differed
y a single base pair compared with strain 17 at residues
6, 50, 58 154, 272, 375, 377, and 550. The changes at
odon 154 and 375 caused an amino acid substitution of
ly to Ser and Val to Ile, respectively. The remaining
hanges did not result in an amino acid substitution.
If the individual revertant viruses were able to over-
ome the block at the cleavage site via different mech-
nisms, they may be expected to produce very different
umbers of progeny viruses per cell in a single round of
rowth. The average burst sizes were determined for the
evertant viruses and for the wild-type strain, KOS. For
OS, the burst size was 1128 PFU/cell. The burst sizes
or PR1, PR5, PR6, PR7, and PR9 were 101, 115, 113, 121,
nd 182 PFU/cell, respectively, which range from 9% to
6% of that found for KOS. PR3 and PR4 had smaller
ields of 38 and 46 PFU/cell, or approximately 4% of wild
ype. These data do not favor reversion by multiple mech-
nisms. Some revertants were temperature sensitive,
nd these data will be presented elsewhere.
nteraction of VP5 with 22a and with 22a-610/611
Revertant viruses were able to replicate in nonpermis-
TABLE 1
Second Site Mutations in the Gene Encoding VP5
Revertant DNA change Codon
Amino-acid
change
PR9 GCG3 GTG 30 Ala3 Val
PR5 CGC3 CAC 34 Arg3 His
PR3 CGC3 TGC 43 Arg3 Cys
GCG3 GTG 365 Ala3 Val
PR7 CGC3 TGC 69 Arg3 Cys
PR2 GCG3 GTG 78 Ala3 Val
PR6 GCG3 GTG 78 Ala3 Val
PR8 GCG3 GTG 78 Ala3 Val
PR4 GCT3 ACT 166 Ala3 Thr
PR1 GCG3 GTG 319 Ala3 Valive cells even though the protease cleavage site be-
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361MAJOR CAPSID PROTEIN (VP5) AND HSV-1ween UL26 residues 610 and 611 of the scaffold protein
emained blocked. The interaction between the VP5 of
hese viruses and the C-termini of the scaffold proteins
ust be weakened to allow VP5 to be freed from the
caffold molecules so B capsids can continue through
he maturation cycle. The yeast two-hybrid system
Fields and Song, 1989) was used to determine the in-
eraction between VP5 of the revertant viruses and 22a
s well as 22a-610/611. In this system, the yeast tran-
criptional activator GAL4 consists of a DNA binding
omain (residues 1–147) and a transcriptional activation
omain (residues 768–881) (Fields and Song, 1989) that
re separable. Fields and colleagues showed that weak
nteractions between proteins fused to each domain can
esult in transcription and translation of a lacZ indicator
ene fused to a GAL4 responsive promoter.
Previously, 86 units of b-galactosidase activity/mg of pro-
ein was reported when VP5 coding sequences were
loned into pGBT9 (DNA binding domain) and 22a se-
uences cloned into pGAD424 (transactivation domain)
Desai and Person, 1996). To determine the b-galactosi-
ase enzyme activity for revertant viruses, the AgeI–BamHI
ragments (specifying codons 11–431 of VP5) from pKKI
lasmids encoding PR3, PR5, PR6, and PR7 were trans-
erred to the yeast two-hybrid plasmid (pGBT9-VP5) cleaved
ith the same enzymes. Sequences from a pKNotI plasmid
ontaining the mutation at UL26 residues 610 and 611 were
ynthesized by PCR and transferred to pGAD424 as de-
cribed previously (Desai and Person, 1996). The authen-
icity of the sequence was confirmed by DNA sequence
nalysis. The interaction of VP5 sequences derived from
he revertants (pGBT9-PR3, pGBT9-PR5, pGBT9-PR6, and
GBT9-PR7) with pGAD424–22a and with pGAD424–22a-
10/611 were measured and compared with the enzyme
ctivity using wild-type VP5 (Table 2). The average number
TABLE 2
Interaction of VP5 with 22a and with 22a-610/611
DNA binding
Transcription activation
pGAD424-22a pGAD424-22a-610/611
Units of
activity %
Units of
activity %
GBT9-VP5 84 100 98 100
GBT9-PR5 89 106 48 49
GBT9-PR3 31 37 16 16
GBT9-PR6 13 16 10 11
GBT9-PR7 0 0 0 0
Note. At least four measurements were made, and the range of
alues for the interaction between pGBT9-VP5 and pGAD424-22a was
7–96 units of b-galactosidase enzyme activity/mg of protein and
1–110 for the interaction between pGBT9-VP5 and pGAD424-22a-610/
11. The ranges were 6 15% of the average values when the VP5 ofpevertant viruses was used.f enzyme units per mg of protein between pGBT9-VP5 with
GAD424–22a was 84, and the average number for the
nteraction between pGBT9-VP5 and pGAD424–22a-610/
11 was 98. Each VP5 mutation resulted in a different
nzyme activity, and the activity was decreased somewhat
hen using 22a molecules with the blocked cleavage site
ompared with wild-type 22a. The enzyme activities were
1% (PR6), 16% (PR3), and 49% (PR5) when used in combi-
ation with pGAD424–22a-610/611. Surprisingly, one mutant
PR7) had no measurable activity in this system.
mount of VP24 in B capsids
Because blockage of the cleavage site resulted in a
ecreased retention of protease (VP24) in B capsids from
he KUL26-610/611 virus, we wondered whether this
ould also be the case for the revertant viruses. To
etermine the relative amount of VP24 in B capsids, a
estern blot procedure was used. Proteins from purified
capsids were separated by SDS–PAGE. After electro-
horetic transfer to a membrane, the proteins were
robed sequentially with an antibody specific for the
-terminus of VP24 (37-93) and with an antibody to the
caffold proteins (MCA-406). Data from one experiment
fter exposure to x-ray film are shown in Fig. 4 for
apsids derived from KOS, PR6, and KUL26-610/611.
ecause the scaffold-specific antibody detected two
roteins (21 and 22a) of slightly different sizes (21 has 58
mino acids at its N-terminus not present in 22a), both of
hich include more than one phosphorylated form, a
road region of radioactivity was observed. In addition,
n overexposure of this region was necessary to detect
P24 that was present at approximately 10-fold lesser
mounts than 22a plus 21. The decreased mobilities
or the scaffold proteins for PR6 and KUL26-610/611 rel-
tive to KOS were due to the 25 amino acids that are
FIG. 4. Western blots of VP24 and scaffold proteins. B capsids were
eparated by SDS–PAGE (15% acrylamide) and transferred to a mem-
rane. The membrane was probed sequentially with primary antibodies
7-93 and MCA-406. 125I-protein A was used as the second antibody.
pproximately twice as much material was loaded onto the lanes for
R6 and for KUL26-610/611 as for KOS. The regions of the membrane
hat correspond to scaffold proteins and to VP24 are indicated. The
obilities of VP24 and scaffold proteins detected by these antibodies
ere identified previously (Person and Desai, 1998).resent due to the blocked scaffold cleavage site. It
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362 DESAI AND PERSONeems from the data shown that there was very little
P24 in KUL26-610/611 capsids and an increased
mount of VP24 in PR6 capsids but definitely less than
he amount observed for B capsids derived from KOS
nfections.
The amount of VP24 relative to scaffold proteins (22a
nd 21) was quantified from Western blots for several
xperiments, including the one shown in Fig. 4, using a
hosphorImager. Data are expressed as a ratio of the
mount of radioactivity detected using an antibody spe-
ific for VP24 divided by the amount determined when an
ntibody was used that detected the scaffold proteins (21
nd 22a). The quantification included all of the radioac-
ivity present in the regions indicated on the side of Fig.
for the scaffold proteins and for VP24. The average
elative amounts of VP24, the number of experimental
eterminations, and standard deviations are shown in
able 3. The amount of radioactivity corresponding to
P24 and to the scaffold proteins for KUL26–620/611, the
hotostimulated light units corresponding to VP24 were
sually about 100 and the number for the scaffold pro-
eins was about 100,000 (see footnote to Table 3). Data
ere obtained using two different exposure times to the
hosphorImager plate, and similar ratios of signal were
lways obtained; therefore, data were judged to be in the
inear range of the PhosphorImager. The relative amount
f VP24 in PR5 and PR6 capsids was approximately 25%
f that found in KOS and 7% for the original mutant virus.
f we take the number of VP24 as 140 per B capsid
Person et al., 1993), then there are about 35 molecules
f VP24 in the revertants and about 10 in KUL26-610/611.
or KUL26-610/611, in one experiment the amount of
P24 was essentially at the background level. If that
atum was included, the amount of VP24 would be 25%
ower than the number given. Similar results were ob-
ained when a rabbit polyclonal antibody against VP5
as used as the internal standard but a number of
T
Relative Amount
Virus
No. of
experiments
37-93 (V
(21
KOS 5 54.4
PR5 2 13.4
PR6 3 13.7
KUL26-610/611 3 3.9
Note. Radioactivity from membranes exposed to a phosphorimaging
s a digital readout in units called photostimulated light (psl). Data are
sl detected by MCA-406 antibodies. The range of psl measured usin
UL26-610/611. The corresponding range of values that was detected
4828-139126 for KUL26-610/611.purious bands limited its usefulness. oDISCUSSION
Nine revertants of a mutant virus (KUL26-610/611) that
ncodes a lethal mutation in the UL26 and UL26.5 ORFs
ere isolated and characterized. All of the revertants
etained an EcoRI site that was added in the construction
f KUL26-610/611 and were therefore due to mutations at
second site. The revertants were extragenic, and DNA
equence analysis showed that all of the amino acid
ubstitutions were in the N-terminus of VP5, which is
omposed of 1374 amino acids. Six of the nine revertants
howed a single base pair change that caused an amino
cid substitution between residues 30 and 78 of VP5.
hree of these were identical and changed Ala to Val at
esidue 78 (PR2, PR6, PR8). The mutations in PR2, PR6,
nd PR8 must be independent because they were iso-
ated from three different plaques. One of the nine rever-
ants had two amino acid substitutions, one at residue 43
nd a second at residue 365 (PR3), which represented
he most C-terminal change for any of the mutations. The
emaining two revertants were due to an Ala-to-Thr
hange at residue 166 and an Ala-to-Val change at res-
due 319. The data provide a partial map of residues of
P5 that alter its interaction with scaffold proteins
locked at their normal cleavage site.
Four residues altered at amino acids 30, 34, 69, and 78
ave rise to revertants. It is tempting to suppose that one
r more of these residues interact directly with residues
n the C-terminus of scaffold molecules. If so, then the
-terminus of VP5 is on the inside of the capsid. The
-terminus of the HSV-1 scaffold molecule is predicted to
ave an a-helical structure. The critical residues, as
udged by mutational analysis, for interaction with VP5
re hydrophobic residues at 623 and 624 (Ala), 627 (Phe),
28 (Val), and 631 and 632 (Met), which are on the same
ide of the amphipathic a-helix (Hong et al., 1996, Oien et
l., 1997). However, we do not have sufficient information
o be able to identify residues of VP5 that may interact
ith the key scaffold residues. The C-terminal residues
4 in B Capsids
CA-406
2a) % of KOS mol/B capsid
1023 100 140
1023 25 34
1023 25 35
1023 7 10
as recovered as light proportional to the stored radiation and recorded
sed as the ratio of net psl detected by 37-93 antibodies divided by the
3 was 231–3368 for KOS, 84–1271 for PR5 and PR6, and 89–281 for
CA-406 was 5089–99562 for KOS, 5119–38062 for PR5 and PR6, andABLE 3
of VP2
P24)/M
and 2
6 23 3
6 3 3
6 1.7 3
6 1.6 3
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363MAJOR CAPSID PROTEIN (VP5) AND HSV-1esponding protein, the coat protein (Parker and Prev-
lige, 1998). In this case, the terminal residues form a
elix-turn-helix structure in which hydrophobic residues
re sequestered on the inside of the two helices with six
ositively charged residues on one side of the helix.
hese residues are presumed to interact with negatively
harged residues of the coat protein. Release of the
caffold is thought to trigger capsid expansion, presum-
bly by electrostatic repulsion.
Revertant viruses are able to replicate in nonpermis-
ive cells even though the protease cleavage site be-
ween UL26 residues 610 and 611 of the scaffold protein
emained blocked. The interaction between the VP5 of
hese viruses and the C-termini of the scaffold proteins
ust be weakened to allow VP5 to be freed from the
caffold molecules so B capsids can continue through
he maturation cycle. Although b-galactosidase enzyme
ctivity in the yeast two-hybrid system does not indicate
he strength of an interaction, the data are consistent
ith a weaker interaction between the mutant VP5 mol-
cules and scaffold molecules blocked at the scaffold
aturation site. The enzyme activities ranged from near
% (PR7) to 50% (PR5) relative to the activity when wild-
ype VP5 sequences were used and assayed using 22a-
10/611 scaffold proteins. The enzyme activities resulting
rom the use of revertant sequences of VP5 interacting
ith the scaffold protein blocked at 610 and 611 were
ess than those with wild-type scaffold molecules. There-
ore, the altered residues probably do not interact di-
ectly with residues at 610 and 611.
Second site mutations have been useful in the study of
acteriophage, including capsid assembly (see, for ex-
mple, Fane et al., 1993; Floor, 1970; Georgopoulos et al.,
973; Jarvik and Botstein, 1975; Sternberg, 1973, 1976;
ap and Rao, 1996). In these studies, the suppressor
utation almost always alters a protein that interacts
ith the original mutant protein. Second site suppres-
ors can overcome a mutant defect via a qualitative or
uantitative (stoichiometric) mechanism. In bacterio-
hage assembly, some suppressor mutations act via a
uantitative mechanism in accordance with a balance of
omponents hypothesis of a key molecule in assembly
athways. The original mutation changes the amount of
key protein, and the suppressor acts by restoring the
rotein balance by changing the concentration of the
nteracting protein. In our study, the suppressors proba-
ly represent the qualitative mechanism and are due to
onformation changes in VP5 that directly or indirectly
lter its interaction with the C-terminal residues of the
caffold proteins.
VP24 is likely to have a function other than its known
nzymatic cleavages. A temperature-sensitive mutant
rotease of HSV-1 exists that regains enzyme activity
hen the temperature is lowered in the absence of
rotein synthesis (Church and Wilson, 1997; Preston et
l., 1983). During incubation at the nonpermissive tem- cerature, B capsids are formed as judged by electron
icroscopy, but they are blocked at an early step in
apsid development. They do not react with VP5 antibody
8F5) specific for hexons found in polyhedral-shaped B
apsids, and their electron microscope morphology is
escribed as large cored (refers to the electron density
attern of the internal scaffold molecules). Upon a tem-
erature shift to 31°C for 20–40 min, immunoreactivity
nd a change in morphology were apparent. A mutant
irus that lacks a protease and a mutant that was
locked at the protease release site between codons
47 and 248 produce capsids blocked at an early step in
apsid development (Gao et al., 1994; Matusick-Kumar et
l., 1995). They do not react with antibody 8F5 and are
ot stable to conditions normally used for capsid purifi-
ation. The mutant that we isolated, KUL26-610/611, pro-
uces B capsids that are stable to biochemical isolation
nd have the polyhedral morphology in the electron mi-
roscope. KUL26-610/611 releases active VP24 mole-
ules at the nonpermissive condition, which distin-
uishes it from other protease mutants isolated to date.
P24 is lost from KUL26-610/611 B capsids formed during
he course of a 24-h infection of nonpermissive cells, but
e have no data as to the time course of the loss of
P24. All of the data from infected mammalian cells are
onsistent with a requirement of VP24 for the conversion
f the less-robust spherical B capsids to the more-stable
olyhedral capsids. The transition of sensitive, spherical
apsids to more stable polyhedral ones has also been
eported for capsids formed in vitro (Newcomb et al.,
996). However, we note that polyhedral B capsids are
ormed during baculovirus infection of insect cells in the
bsence of VP24 (Tatman et al., 1994; Thomsen et al.,
994).
The lack of retention of VP24 in KUL26-610/611 B
apsids in nonpermissive cells implies that normally,
omething is required for its retention, such as a confor-
ation change, autoproteolytic cleavage, or an interac-
ion with another capsid molecule. When cleavage is
locked, second site mutations in VP5 may cause the
elease of scaffold molecules and the retention of in-
reased quantities of VP24 in B capsids. VP24 appears to
otentiate the conversion of less-stable, spherical to
table, polyhedral capsids, and probably for later steps
n capsid maturation as well. We propose that VP24 may
erform a structural protein role in DNA packaging by
nteracting with VP5 (perhaps with the 12 pentons). The
ormation of a molecular complex of 1 dimer of VP24/VP5
olecule would be consistent with 140 molecules of
P24/capsid. The postulated binding of VP24 to VP5 in
entons (or hexons) may be cooperative to ensure that
ll binding sites at a particular penton (or hexon) are
illed. VP24 has a well-characterized enzyme activity
hose active site is an antiviral target. The molecularharacterization of a structural role of VP24 in capsid
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364 DESAI AND PERSONaturation could lead to the development of a second
ntiviral compound.
MATERIALS AND METHODS
ammalian cells and viruses
Vero and C32 cells (Person and Desai, 1998) were
rown in Eagle’s minimum essential medium supple-
ented with 10% FCS (GIBCO BRL, Gaithersburg, MD).
irus stocks were prepared as described by Desai et al.
1998).
NA preparation
For Southern blots, DNA was obtained from 3 3 105
ells (confluent cells in a single well of a 12-well tray)
nfected at a multiplicity of infection (m.o.i.) of 10 PFU/
ell. The infected cells were generally harvested 24 h
fter infection. The cell pellet was resuspended in Pro-
einase-K digestion buffer (10 mM Tris–HCl, pH 8.0, 10
M EDTA, 0.6% SDS, and 250 mg/ml Proteinase-K; Boe-
ringer-Mannheim, Indianapolis, IN) and incubated at
7°C overnight. The lysate was phenol–chloroform ex-
racted, and the DNA was precipitated with ethanol and
esuspended in Tris–HCl buffer (10 mM, pH 7.5). South-
rn blot analysis was performed as described by Desai
t al. (1993).
KUL26-610/611 DNA for marker-transfer experiments
as obtained from approximately 20 3 106 cells infected
t an m.o.i. of 5 PFU/cell. Infected cells were harvested,
nd DNA was prepared as for Southern blots.
PR7 DNA for marker transfer was obtained from ap-
roximately 108 cells (five T150 cm2 flasks) infected at an
.o.i. of 0.01 PFU/cell, and viruses were harvested 3
ays later. Intracellular and released virions were pel-
eted and sedimented to equilibrium through 30–65%
ucrose (Desai et al., 1994). Purified virions were visible
s a light scattering band and were collected by side
ube puncture. DNA was prepared as for Southern blots
nd was treated with EcoRI restriction endonuclease; the
esulting pool of 13 fragments was used in the marker-
ransfer experiment. Individual EcoRI fragments were
loned from the pool of fragments and used in other
arker-transfer experiments.
NA sequencing
The HSV-1 KpnI-I fragments encoding UL18, UL19, and
L20 (McGeoch et al., 1988) of the revertant viruses were
loned into KpnI cleaved pUC19, and these plasmids
ere used for DNA sequence analysis. Sequence anal-
sis of the 59 coding region of VP5 used oligonucleotides
18 mers) whose 59 nucleotides were complementary to
ucleotides 75, 399, 849, 1011, and 1194 relative to the
tart of translation of the UL19 ORF and to 40 nucleotides
pstream of the start of translation. Sequence analysis of
ne strand was performed at the Johns Hopkins School hf Medicine Core Facility and were compared with that of
he same region of VP5 encoded by strain 17 (McGeoch
t al., 1988), KOS, and KUL26-610/611 with use of the
rogram Sequencher (Gene Codes, Ann Arbor, MI).
ingle step growth
Vero cell monolayers in 6-well trays were infected in
uplicate with viruses (0.1 ml/well) at a concentration of
08 PFU/ml. After 1-h absorption, unabsorbed viruses
ere removed, 1 ml of growth medium was added to
ach well, and incubation was continued for 24 h. Vi-
uses were harvested, sonicated, and enumerated by
laque assay. Burst sizes were calculated using 7.5 3
05 cells as the number of Vero cells per well. Wells were
eeded with 5.5 3 105 cells 16 h before infection.
estern blots
In most experiments, 4, 8, and 12 T150 cm2 flasks of
ero cell monolayers (approximately 2 3 107 cells/flask)
ere infected with KOS, revertants, and KUL26-610/611
iruses, respectively, at an m.o.i. of 5 PFU/cell. After a
4-h incubation, viruses were harvested and sonicated,
nd nuclear extracts from two T150 flasks were loaded
nto sucrose gradients in SW41 tubes (Desai et al.,
993). After sedimentation, capsids were visible by light
cattering. B capsid bands were collected, pelleted, and
esuspended in Laemmli’s buffer. Proteins were sepa-
ated using SDS–PAGE (Desai et al., 1993). Electrophore-
is and transfer of separated proteins were accom-
lished with a minigel apparatus and procedures sup-
lied by BioRad (Hercules, CA). Separated proteins on
mmobilon-P membranes (Millipore, Bedford, MA) were
xposed sequentially to primary antibodies 37-93 and
CA-406, probed with 125I-protein A (DuPont-NEN, Bos-
on, MA), washed, and air dried before autoradiography
r quantification. Membranes were exposed to x-ray film
r to a Fuji BAS-III imaging plate for quantification using
PhosphorImager (FUJIX BAS 1000). Peptide antibodies
pecific to amino acids 4–18 of UL26 (antibody 37-93)
ere generously provided by Dr. R. LaFemina and gen-
rated under the direction of Dr. Tony Conley (Merck
esearch Laboratories, West Point, PA). Monoclonal an-
ibody MCA-406 detects scaffold proteins 21 and 22a and
as obtained from Serotec (Oxford, UK).
ata presentation
Autoradiographs for Figs. 2–4 were scanned on a
max Powerlook II scanner. The images were scanned
t 300 dots per inch into Adobe Photoshop 3.0 and were
ransported as PICT files into Microsoft Powerpoint for
igure presentation and printing.
ACKNOWLEDGMENTS
The research was supported by Grant AI33077. It is a pleasure to
ave discussed experiments with Neal A. DeLuca and Wade Gibson
a
G
i
B
b
B
B
C
C
D
D
D
D
D
D
F
F
F
G
G
G
H
H
H
J
K
L
L
L
M
M
M
N
N
N
N
O
P
P
365MAJOR CAPSID PROTEIN (VP5) AND HSV-1nd with members of the Gibson Lab. The technical assistance of
abriela Chytrova is also acknowledged. Similar experiments were
nitiated several years ago in collaboration with Patrick McCann III of
ristol-Myers Squibb. Several difficulties were encountered, and a virus
locked at the maturation cleavage site was never isolated.
REFERENCES
ooy, F. P., Newcomb, W. W., Trus, B. L., Brown, J. C., Baker, T. S., and
Steven, A. C. (1991). Liquid-crystalline phage-like packing of encap-
sidated DNA in herpes simplex virus. Cell 64, 1007–1015.
ooy, F. P., Trus, B. L., Newcomb, W. W., Brown, J. C., Conway, J. F., and
Steven, A. C. (1994). Finding a needle in a haystack: Detection of a
small protein (the 12-kDa VP26) in a large complex (the 200-MDa
capsid of herpes simplex virus). Proc. Natl. Acad. Sci. USA 91,
5652–5656.
hurch, G. A., and Wilson, D. W. (1997). Study of herpes simplex virus
maturation during a synchronous wave of assembly. J. Virol. 71,
3603–3612.
ohen, G. H., Ponce de Leon, M., Diggleman, H., Lawrence, W. C.,
Vernon, S. K., and Eisenberg, R. J. (1980). Structural analysis of the
capsid polypeptides of herpes simplex virus types 1 and 2. J. Virol.
34, 521–531.
esai, P., DeLuca, N. A., Glorioso, J. C., and Person, S. (1993). Mutations
in herpes simplex virus type 1 genes encoding VP5 and VP23
abrogate capsid formation and cleavage of replicated DNA. J. Virol.
67, 1357–1364.
esai, P., DeLuca, N. A., and Person, S. (1998). Herpes simplex virus
type 1 VP26 is not essential for replication in cell culture but influ-
ences production of infectious virus in the nervous system of in-
fected mice. Virology 247, 115–124.
esai, P., Homa, F. L., Person, S., and Glorioso, J. C. (1994). A genetic
selection method for the transfer of HSV-1 glycoprotein B mutations
from plasmid to the viral genome: Preliminary characterization of
transdominance and entry kinetics of mutant viruses. Virology 204,
312–322.
esai, P., and Person, S. (1996). Molecular interactions between the
HSV-1 capsid proteins as measured by the yeast two-hybrid system.
Virology 220, 516–521.
esai, P., Watkins, S. C., and Person, S. (1994). The size and symmetry
of B capsids of herpes simplex virus type 1 are determined by the
gene products of the UL26 open reading frame. J. Virol. 68, 5365–
5374.
iIanni, C. L., Drier, D. A., Deckman, I. C., McCann, P. J., Liu, F., Roizman,
B., Colonno, R. J., and Cordingly, M. G. (1993). Identification of the
herpes simplex virus-1 protease cleavage sites by direct sequence
analysis of autoproteolytic cleavage products. J. Biol. Chem. 268,
2048–2051.
ane, B. A., Shien, S., and Hayashi, M. (1993). Second-site suppressors
of a cold-sensitive external scaffolding protein of bacteriophage
FX174. Genetics 134, 1003–1011.
ields, S., and Song, O-k. (1989). A novel genetic system to detect
protein-protein interactions. Nature 340, 245–246.
loor, E. (9170). Interaction of morphogenetic genes of bacteriophage
T4. J. Mol. Biol. 47, 293–306.
ao, M., Matusick-Kumar, L., Hurlburt, W., DiTusa, S. F., Newcomb,
W. W., Brown, J. C., McCann, P. J., Deckman, I., and Colonno, R. J.
(1994). The protease of herpes simplex virus type I is essential for
functional capsid formation and viral growth. J. Virol. 68, 3702–3712.
eorgopoulos, C. P., Hendrix, R. W., Casjens, S. R., and Kaiser, A. D.
(1973). Host participation in bacteriophage lambda head assembly. J.
Mol. Biol. 76, 45–60.
ibson, W., and Roizman, B. (1972). Proteins specified by herpes sim-
plex virus. VIII. Characterization and composition of multiple capsid
forms of subtypes 1 and 2. J. Virol. 10, 1044–1052.
eilman, C. J., Zweig, M., Stephenson, J. R., and Hampar, B. (1979).
Isolation of a nucleocapsid polypeptide of herpes simplex virus types1 and 2 possessing immunologically type specific and cross-reactive
determinants. J. Virol. 29, 34–42.
olland, L. E., Sandri-Goldin, R. M., Goldin, A. L., Glorioso, J. C., and
Levine, M. (1984). Transcriptional and genetic analyses of the herpes
simplex virus type 1 genome: Coordinates 0.29 to 0.45. J. Virol. 49,
947–959.
ong, Z., Beaudet-Miller, M., Durkin, J., Zhang, R., and Kwong, A D.
(1996). Identification of a minimal hydrophobic domain in the herpes
simplex virus type 1 scaffolding protein which is required for inter-
action with the major capsid protein. J. Virol. 70, 533–540
arvik, J., and Botstein, D. (1975). Conditional-lethal mutations that
suppress genetic defects in morphogenesis by altering structural
proteins. Proc. Natl. Acad. Sci. USA 72, 2738–2742.
ennard, J., Rixon, F. J., McDougall, I. M., Tatman, J. D., and Preston,
V. G. (1995). The 25 amino acid residues at the carboxyl terminus of
the herpes simplex virus type 1 UL26.5 protein are required for the
formation of the capsid shell around the scaffold. J. Gen. Virol. 76,
1611–1621.
iu, F., and Roizman, B. (1991a). The promoter, transcriptional unit, and
coding sequences of the herpes simplex virus 1 family 35 proteins
are contained within and in frame with the UL26 open reading frame.
J. Virol. 65, 206–212.
iu, F., and Roizman, B. (1991b). The herpes simplex virus type 1 gene
encoding a protease also contains within its coding domain the gene
encoding the more abundant substrate. J. Virol. 65, 5149–5156.
iu, F., and Roizman, B. (1993). Characterization of the protease and
other products of amino-terminus-proximal cleavage of the herpes
simplex virus 1 UL26 protein. J. Virol. 67, 1300–1309.
atusick-Kumar, L., McCann, P. J., Robertson, B. J., Newcomb, W. W.,
Brown, J. C., and Gao, M. (1995). Release of the catalytic domain No
from the herpes simplex virus type 1 protease is required for viral
growth. J. Virol. 69, 7113–7121.
atusick-Kumar, L., Newcomb, W. W., Brown, J. C., McCann, P. J.,
Hurlbert, W., Weinheimer, S. P., and Gao, M. (1995). The C-terminal 25
amino acids of the protease and its substrate ICP35 of herpes
simplex virus type 1 are involved in the formation of sealed capsids.
J. Virol. 69, 4347–4356.
cGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C.,
McNab, D., Perry, L. J., Scott, J. E., and Taylor, P. (1988). The complete
DNA sequence of the long unique region in the genome of herpes
simplex virus type 1. J. Gen. Virol. 69, 1531–1574.
ewcomb, W. W., Brown, J. C., Booy, F. P., and Steven, A. C. (1989).
Nucleocapsid mass and capsomer protein stoichiometry in equine
herpes virus type 1: A scanning transmission electron microscopic
study. J. Virol. 63, 3777–3783.
ewcomb, W. W., Homa, F. L., Thomsen, D. R., Booy, F. P., Trus, B. L.,
Steven, A. C., Spencer, J. V., and Brown, J. C. (1996). Assembly of the
herpes simplex virus capsid: Characterization of intermediates ob-
served during cell-free capsid formation. J. Mol. Biol. 263, 432–446.
ewcomb, W. W., Trus., B. L., Booy, F. P., Steven, A. C., Wall, J. S., and
Brown, J. C. (1993). Structure of the herpes simplex virus capsid:
Molecular composition of the pentons and the triplexes. J. Mol. Biol.
232, 499–511.
icholson, P., Addison, C., Cross, A. M., Kennard, J., Preston, V. G., and
Rixon, F. J. (1994). Localization of the herpes simplex virus type 1
major capsid protein VP5 to the cell nucleus requires the abundant
scaffolding protein VP22a. J. Gen. Virol. 75, 1091–1099.
ien, N. L., Thomsen, D. R., Wathen, M. W., Newcomb, W. W., Brown,
J. C., and Homa, F. L. (1997). Assembly of herpes simplex virus
capsids using the human cytomegalovirus scaffold protein: Critical
role of the C terminus. J. Virol. 71, 1281–1291.
raker, M. H., and Prevelige, P. E., Jr. (1998). Electrostatic interactions
drive scaffolding/coat protein binding and procapsid maturation in
bacteriophage P22. Virology 250, 337–349.
erson, S., and Desai, P. (1998). Capsids are formed in a mutant virus
blocked at the maturation site of the UL26 and UL26.5 open reading
PP
P
R
S
S
S
S
S
T
T
T
T
T
W
Y
Z
Z
366 DESAI AND PERSONframe of HSV-1 but are not formed in a null mutant of UL38 (VP19C).
Virology 242, 193–203.
erson, S., Laquerre, S., Desai, P., and Hempel, J. (1993). Herpes
simplex virus type 1 capsid protein, VP21, originates within the UL26
open reading frame. J. Gen. Virol. 74, 2269–2273.
reston, V. G., Coates, J. A. V., and Rixon, F. J. (1983). Identification and
characterization of a herpes simplex virus gene product required for
encapsidation of virus DNA. J. Virol. 45, 1056–1064.
reston, V. G., Rixon, F, J., McDougall, I. M., McGregor, M., and Al
Kobaisi, M. F. (1992). Processing of the herpes simplex virus assem-
bly protein ICP35 near its carboxy terminal end requires the product
of the whole of the UL26 reading frame. Virology 186, 87–98.
ixon, F. J., Addison, C., McGregor, A., MacNab, S. J., Nicholson, P.,
Preston, V. G., and Tatman, J. D. (1996). Multiple interactions control
the intracellular localization of the herpes simplex virus type 1 capsid
proteins. J. Gen. Virol. 77, 2251–2260.
hepard, A. A., and DeLuca, N. A. (1991). A second-site revertant of a
defective herpes simplex virus ICP4 protein with restored regulatory
activities and impaired DNA-binding properties. J. Virol. 65, 787–795.
oliman, T. M., Sandri-Goldin, R. M., and Silverstein, S. J. (1997). Shut-
tling of the herpes simplex virus type 1 regulatory protein ICP27
between the nucleus and the cytoplasm mediates the expression of
late proteins. J. Virol. 71, 9188–9197.
ternberg, N. (1973). Properties of a mutant of Escherichia coli defec-
tive in bacteriophage a head formation (groE). II. The propagation of
phage a. J. Mol. Biol. 76, 25–44.
ternberg, N. (1976). A genetic analysis of bacteriophage a head
assembly. Virology 71, 568–582.
teven, A. C., and Spear, P. G. (1996). Herpesvirus capsid assembly and
envelopment. In “Structural Biology of Viruses” (R. Burnett, W. Chiu,
and R. Garcea, Eds.), pp. 312–351. Oxford University Press, New York.
atman, J. D., Preston, V. G., Nicholson, P., Elliot, R. M., and Rixon, F. J.
(1994). Assembly of herpes simplex type 1 capsids using a panel of
recombinant baculoviruses. J. Gen. Virol. 75, 1101–1113.homsen, D. R., Newcomb, W. W., Brown, J. C., and Homa, F. L. (1995).Assembly of the herpes simplex virus capsid: Requirement for the
carboxyl-terminal twenty-five amino acids of the proteins encoded by
the UL26 and UL26.5 genes. J. Virol. 69, 3690–3703.
homsen, D. R., Roof, L. L., and Homa, F. L. (1994). Assembly of herpes
simplex virus (HSV) intermediate capsids in insect cells infected with
recombinant baculoviruses expressing HSV capsid proteins. J. Virol.
68, 2442–2457.
rus, B. L., Booy, F. P., Newcomb, W. W., Brown, J. C., Homa, F. L.,
Thomsen, D. R., and Steven, A. C. (1996). The herpes simplex virus
procapsid: Structure, conformational changes during maturation, and
roles of the triplex proteins, VP19C and VP23 in assembly. J. Mol. Biol.
263, 447–462.
rus, B. L., Homa, F. L., Booy, F. P., Newcomb, W, W., Thomsen, D. R.,
Cheng, N., Brown, J. C., and Steven, A .C. (1995). Herpes simplex
virus capsids assembled in insect cells infected with recombinant
baculoviruses: Structural authenticity and localization of VP26. J. Vi-
rol. 69, 7362–7366.
einheimer, S. J. McCann, P. J., O’Boyle, D. R., Stevens, J. T., Boyd, B. A.,
Drier, D. A., Yamanaka, G. A., DiIanni, C. L., Deckman, I. C., and
Cordingly, M. G. (1993). Autoproteolysis of herpes simplex virus type
1 protease releases an active catalytic domain found in intermediate
capsid particles. J. Virol. 67, 5813–5822.
ap, N. L., and Rao, V. B. (1996). Novel mutants in the 59 upstream
region of the portal protein gene 20 overcome a gp40-dependent
prohead assembly block in bacteriophage T4. J. Mol. Biol. 263,
539–550.
hou, Z. H., He, J., Jakana, J., Tatman, J. D., Rixon, F. J., and Chiu, W.
(1995). Assembly of VP26 in herpes simplex virus-1 inferred from
structures of wild-type and recombinant capsids. Nat. Struct. Biol. 2,
1026–1030.
hou, Z. H., Prasad, B. V. V., Jakana, J., Rixon, F. J., and Chiu, W. (1994).
Protein subunit structures in herpes simplex virus A-capsid deter-
mined from 400 kV spot-scan electron microscopy. J. Mol. Biol. 242,
456–469.
